GeneralConnection.com ➔ Dictionary
Dictionary Search

pharma

Synonyms

Noun

1. drug company

2. pharmaceutical company, company

Usage
The space race is coming for pharma: Why drug development is heading to lower Earth orbit - CNBC
DSV launches Luxembourg–Indianapolis pharma air route - Air Cargo News
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery - Fierce Biotech
Teva to lay off 250 at API unit as search for new owner drags on: report - Fierce Pharma
The looming China pharma choke point - Axios
Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot’s Side Effects - WSJ
Who pays the best (and worst) in biopharma? A look at typical employee salaries - Endpoints News
AstraZeneca unveils data behind Phase III-bound oral GLP-1 - FirstWord Pharma
Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat - Reuters
Is this the end of costly and harmful pharmaceutical advertising? - The Hill
Five things for pharma marketers to know for Wednesday, June 10, 2026 - Medical Marketing and Media
Justices reject holding generic pharmaceutical manufacturers liable for decisions of pharmacists about prescribing their products - SCOTUSblog
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region - BioSpace
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner - Pharmaceutical Executive
Pharma groups say SUPAC guidelines should be updated, better aligned with ICH - RAPS.org
Symeres Expands Spray Drying Capabilities in Cranbury, NJ - Contract Pharma
ORIC Pharmaceuticals Positions for Growth in Expanding Oncology Market - Streetwise Reports
Pharma's Competitive Advantage at AUTOMA+ 2026 - healthcare-in-europe.com
Build AI-Ready Pharma R&D to Accelerate Drug Development, Upcoming Webinar Hosted by Xtalks - PR Newswire
News Airfreight must prepare for a new wave of pharma – 'current processes won't work' - The Loadstar
From Clinical To Market: Managing Pharma's Most Challenging Transition - Life Science Leader
DSV expands pharma air network - Container News
Novartis returns to Orionis inking $1.4B molecular glue pact - FirstWord Pharma
DSV launches direct Luxembourg–Indianapolis pharma air route to improve temperature-controlled deliveries - American Journal of Transportation
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity - BioSpace
What Could Happen When Israel’s Pharma Giant Meets Its Most Innovative Hospital? - The Media Line
The Oral GLP-1 Tracker: Week 1 of Lilly's Foundayo launch - Fierce Pharma
FDA Approves EBGLYSS 8-Week Dosing - Contract Pharma
Orionis Biosciences, Novartis Partner to Advance Molecular Glue Drugs - Contract Pharma
Dangerous waters: Geopolitics, supply chains and access to medicines - Pharmaceutical Technology
Alnylam expands Genesis Pharma deal in Europe (ALNY:NASDAQ) - Seeking Alpha
FibroFind Names New CEO, Adds Three Senior Hires - Contract Pharma
Sanofi ends late-stage study of neurology drug riliprubart - FirstWord Pharma
Europe's Big Pharma Could Win Investors' Favor With Busy End of Year -- Market Talk - Moomoo
GSK Acquires Nuvalent for $10.6 Billion | PharmExec - Pharmaceutical Executive
The Pharma Choke Point - Council on Foreign Relations
Injectable Drug Sterilization: Key Challenges and Strategies - Contract Pharma
Ascendis Pharma (ASND):10 Most Profitable Growth Stocks to Buy - Yahoo Finance
B.Riley initiates Ascentage Pharma stock with buy, $45 target - Investing.com
Pharma stocks are showing strength. Charts predict this name could break out next - CNBC
Managing the Transition to a Multipolar Pharma Market - Bain & Company
From Dashboards to Decisions: How AI Is Reshaping Pharma Brand Strategy - Pharmaceutical Executive
Genesis Pharma expands Alnylam partnership to Nordic markets - Investing.com
Yaneth Giha elected Vice Chair of global pharmaceutical trade body - PR Newswire
Yomiuri: Sumitomo Pharma Readies for Wider Sales of iPS Cell Therapy Amchepry - MarketWatch
ECU’s Pharma Conference highlights life sciences in eastern NC - East Carolina University
AlzeCure Enters $1 Billion Collaboration and Out-Licensing Agreement with Eli Lilly - Pharmaceutical Executive
Beyond Profit: A Pharma-Nonprofit Alliance Targets Nano-Rare Diseases - BriefGlance
Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement - Pharmaceutical Technology
Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts - South China Morning Post
Evogene to Present Its Pharma Division Achievements at the BIO International Convention - PR Newswire
Patents or patients? Two camps form over EU's new pharma perks - Euractiv
AlzeCure Pharma: From lab to Lilly – A historic USD1bn validation - TradingView
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering - Pharmaceutical Executive
Pharma in Spain: why global investors and innovators are moving in - Labiotech.eu
Assessing Ascendis Pharma (ASND) Valuation After Recent Share Price Weakness - Yahoo Finance
Swiss pharma company to acquire North Augusta drug manufacturer site - AOL.com
Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals - Yahoo Finance
The Future of Biotech Outsourcing - Contract Pharma
Genesis and Alnylam Expand Partnership to Commercialize RNAi Therapeutics for Nordic Region - Contract Pharma
The biotech start-up factory changes shape - The Pharma Letter
Why The Narrative Around Zealand Pharma (CPSE:ZEAL) Is Shifting After Target Resets And Trial Updates - Yahoo Finance
AI Vaccine Clears Human Trials, Handing Pharma a New Playbook - PYMNTS.com
The EU Pharma Package: What U.S. Companies Need to Know - The National Law Review
Parabilis sets a record with a $670M biotech IPO - BioPharma Dive
CenterBook Partners LP Has $2.71 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Danny Williams on What the Next Five Years Hold for Pharma 3PLs - Pharmaceutical Commerce
Novartis sticks 2nd deal with molecular glue biotech Orionis, this one worth up to $1.4B - Fierce Biotech
Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery - Yahoo Finance Singapore
Beyond the Pill: How Roquette Is Building Pharma's Future in Asia - BriefGlance
Supply Chain Modernization is Now Strategy: What Pharma Leaders Must Get Right - Pharmaceutical Executive
11th GCC Regulatory Affairs Summit to Address the Next Wave of Ph - The National Law Review
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time - TMX Newsfile
Merck, Gilead score in effort to develop the first weekly HIV pill - Fierce Pharma
CatalYm Announces New Chief Financial Officer Peter Garcia - Contract Pharma
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Parabilis Medicines sets biotech record with $670m IPO - Pharmaceutical Technology
UBS highlights several factors that could boost healthcare stocks - medwatch.com
Amid a flurry of biotech deals, China looks to keep innovation at home - Pharma Voice
How Specialty Pharmacies Are Redefining Their Role in the Patient Journey - Pharmaceutical Commerce
Novo Nordisk faces off in court with South African weight-loss drug compounder - Reuters
Cronus Pharma Introduces FDA Approved Generic Chewable Tablets for Canine Cardiac Care - Pet Age
Orionis inks molecular glue collaboration with Novartis - The Pharma Letter
Parabilis targets $745 million in record-setting biotech IPO - The Pharma Letter
India’s Top Bank in $1 Billion Funding for Sun Pharma’s US Deal - Bloomberg.com
Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology - MarketWatch
Committee Approves Pennycuick Measure to Modernize PA Pharmaceutical Licensing - Pennsylvania Senate Republicans
4 Large-Cap Pharma Stocks to Buy as Industry Recovery Accelerates - Yahoo Finance
Novugen Pharma (USA) LLC Launches ANDA-Approved Everolimus Tablets in the U.S. - PR.com
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says - Reuters
ATR: Pharma-led growth, innovation in drug delivery, and operational recovery drive future performance - TradingView
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts - BioSpace
The innovation trap: How pharma weaponizes a word to extend monopolies - statnews.com
How Daiichi Sankyo aims to become a top five oncology player by 2035 - Labiotech.eu
Exklusiv | ByteDances KI-Pharma-Sparte bereitet Spin-off-Finanzierung vor: AI4S tritt in die Industrialisierungsphase ein - 36 Kr
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 - Yahoo Finance
Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia - The Manila Times
Drug warranties in pharma puzzle: healthcare coverage - Marsh
WuXi AppTec Added to Pentagon’s Chinese Military List: Impact on Pharma Ties Seen as Minimal - News and Statistics - IndexBox
Apotex Health shares jump in Toronto stock market debut - Reuters
Foreign Language Equivalents
Foreign Language Equivalents of 'pharma'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
phar,a,   pgarma,   pharmma,   phama,   phrama,   pahrma,   pharna,   hparma,   pjarma,   phrma,   [harma,   oharma,   pharrma,   phatma,   pharm,   phamra,   harma,   phaema,   parma,   phharma,   ppharma,   pharmaa,   phsrma,   pharam,   phaarma,   phara,   pharms
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z